Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza

Vaccine

Volumn 32, Issue 6, 2014, Pages 657-663

  Rinaldi, Stefano ^a   Zangari, Paola ^b   Cotugno, Nicola ^b   Manno, Emma Concetta ^b   Brolatti, Noemi ^b   Castrucci, Maria Rita ^c   Donatelli, Isabella ^c   Rossi, Paolo ^b   Palma, Paolo ^b   Cagigi, Alberto ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

AIDS; B cell ELISpot; B cells; ELISpot; HI; Immune compromised; Seasonal influenza; Vaccination response

Indexed keywords

INFLUENZA VACCINE;

ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; PRIORITY JOURNAL; SEASONAL INFLUENZA; SEROCONVERSION;

AIDS; B-CELL ELISPOT; B-CELLS; ELISPOT; ENZYME-LINKED IMMUNOSORBENT SPOT; HEMAGGLUTINATION INHIBITION; HI; IMMUNE-COMPROMISED; SEASONAL INFLUENZA; VACCINATION RESPONSE;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ANTIBODY FORMATION; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; VACCINATION; VACCINES, INACTIVATED; VIRAL LOAD; YOUNG ADULT;

EID: 84893012020     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.12.008     Document Type: Article

References (25)

1. Cohen J.P., Macauley C. Susceptibility to influenza A in HIV-positive patients. JAMA 1989, 261:245.
2. Fine A.D., Bridges C.B., De Guzman A.M., Glover L., Zeller B., Wong S.J., et al. Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City. Clin Infect Dis 2001, 32:1784-1791.
3. Fiore A.E., Shay D.K., Haber P., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 2007, 56:1-54.
4. Neuzil K.M., Coffey C.S., Mitchel E.F., Griffin M.R. Cardiopulmonary hospitalizations during influenza season in adults and adolescents with advanced HIV infection. J Acquir Immune Defic Syndr 2003, 34:304-307.
5. Radwan H.M., Cheeseman S.H., Lai K.K., Ellison I.R. Influenza in human immunodeficiency virus-infected patients during the 1997-1998 influenza season. Clin Infect Dis 2000, 31:604-606.
6. Lin J.C., Nichol K.L. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch Intern Med 2001, 161:441-446.
7. Fuller J.D., Craven D.E., Steger K.A., Cox N., Heeren T.C., Chernoff D. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis 1999, 28:541-547.
8. Kroon F.P., van Dissel J.T., de Jong J.C., Zwinderman K., van Furth R. Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. Vaccine 2000, 18:3040-3049.
9. Bickel M., Wieters I., Khaykin P., Nisius G., Haberl A., Stephan C., et al. Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients. AIDS (London, England) 2010, 24:F31-F35.
10. Tebas P., Frank I., Lewis M., Quinn J., Zifchak L., Thomas A., et al. Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals. AIDS (London, England) 2010, 24:2187-2192.
11. Frasca D., Diaz A., Romero M., Phillips M., Mendez N.V., Landin A.M., et al. Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine. Int Immunol 2012, 3:175-182.
12. Pensieroso S., Cagigi A., Palma P., Nilsson A., Capponi C., Freda E., et al. Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children. Proc Natl Acad Sci USA 2009, 106:7939-7944.
13. Cagigi A., Cotugno N., Giaquinto C., Nicolosi L., Bernardi S., Rossi P., et al. Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions. Hum Vaccines Immunother 2012, 8.
14. Cagigi A., Nilsson A., Pensieroso S., Chiodi F. Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy. Lancet Infect Dis 2010, 10:499-503.
15. Menson E.N., Mellado M.J., Bamford A., Castelli G., Duiculescu D., Marczyńska M., et al. Guidance on vaccination of HIV-infected children in Europe. HIV Med 2012, 6:333-336.
16. Abzug M.J. Vaccination in the immunocompromised child: a probe of immune reconstitution. Pediatr Infect Dis J 2009, 28:233-236.
17. Pradeu T., Jaeger S., Vivier E. The speed of change: towards a discontinuity theory of immunityα. Nat Rev Immunol 2013, 10:764-769.
18. Cagigi A., Pensieroso S., Ruffin N., Sammicheli S., Thorstensson R., Pan-Hammarstrom Q., et al. Relation of activation-induced deaminase (AID) expression with antibody response to A(H1N1)pdm09 vaccination in HIV-1 infected patients. Vaccine 2013, 31:2231-2237.
19. Titanji K., De Milito A., Cagigi A., Thorstensson R., Grutzmeier S., Atlas A., et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 2006, 108:1580-1587.
20. McCullers J.A., Huber V.C. Correlates of vaccine protection from influenza and its complications. Hum Vaccines Immunother 2012, 8:34-44.
21. Madhi S.A., Dittmer S., Kuwanda L., Venter M., Cassim H., Lazarus E., et al. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial. AIDS (London, England) 2013, 27:369-379.
22. DiazGranados C.A., Denis M., Plotkin S. Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. Vaccine 2012, 31:49-57.
23. Joo H.M., He Y., Sundararajan A., Huan L., Sangster M.Y. Quantitative analysis of influenza virus-specific B cell memory generated by different routes of inactivated virus vaccination. Vaccine 2010, 28:2186-2194.
24. Palma P., Romiti M.L., Bernardi S., Pontrelli G., Mora N., Santilli V., et al. Safety and immunogenicity of a monovalent MF59(R)-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults. Biologicals 2012, 40:134-139.
25. Morens D.M., Taubenberger J.K., Fauci A.S. Pandemic influenza viruses-hoping for the road not taken. N Engl J Med 2013, 368:2345-2348.